Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
PASC Post Acute Sequelae of COVID 19 clinical trials
Every US clinical trial registered for PASC Post Acute Sequelae of COVID 19 — phase mix, recruiting status, and the sponsors running them, straight from the NIH ClinicalTrials.gov registry.
5 US clinical trials · 2 currently recruiting
The research picture
PASC Post Acute Sequelae of COVID 19 has 5 registered US clinical trials, 2 of them open to new participants right now — about 40% of the total.
- 2
- recruiting participants now
- 40%
- of trials open to enrollment
- 0
- in Phase 3–4 (later-stage)
- 1
- top sponsor: Bateman Horne Center
Counts reflect the public ClinicalTrials.gov registry as last mirrored by PlainTrial. Status and phase are reported by each study's sponsor. This is reference information, not medical advice.
Active & Recent Trials
Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
Hugo W. Moser Research Institute at Kennedy Krieger
NCT07278388
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
University of New Mexi
NCT06940609
Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2
Massachusetts General Hospital
NCT05040659
A Pilot rTMS Trial for Neuropsychiatric Symptoms of Long-COVID
University of California, Los Angeles
NCT06586398
Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Bateman Horne Center
NCT06316843
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the PASC Post Acute Sequelae of COVID 19 Trial Landscape
ClinicalTrials.gov lists 5 US studies indexed under PASC Post Acute Sequelae of COVID 19, and 2 of those are currently open to recruitment — roughly 40% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for PASC Post Acute Sequelae of COVID 19 shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for PASC Post Acute Sequelae of COVID 19 is led by Bateman Horne Center with 1 indexed trial, alongside 4 other organizations in the top contributor list. The list on this page surfaces up to 5 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for PASC Post Acute Sequelae of COVID 19?
PlainTrial tracks 5 US clinical trials for PASC Post Acute Sequelae of COVID 19, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for PASC Post Acute Sequelae of COVID 19?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.